Sensitivity of monkey B virus (Cercopithecine herpesvirus 1) to antiviral drugs: Role of thymidine kinase in antiviral activities of substrate analogs and acyclonucleosides

Antimicrobial Agents and Chemotherapy

Volumn 51, Issue 6, 2007, Pages 2028-2034

  Focher, Federico ^a   Lossani, Andrea ^a   Verri, Annalisa ^a   Spadari, Silvio ^a   Maioli, Andrew ^b   Gambino, Joseph J ^b   Wright, George E ^b   Eberle, Richard ^c   Black, Darla H ^c   Medveczky, Peter ^d   Medveczky, Maria ^d   Shugar, David ^e  

^a CNR   (Italy)

^b GLSYNTHESIS INC   (United States)

^c OKLAHOMA STATE UNIVERSITY   (United States)

^d UNIVERSITY OF SOUTH FLORIDA   (United States)

^e INSTITUTE OF BIOCHEMISTRY AND BIOPHYSICS   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 9 (4 HYDROXYBUTYL) 6 OXOPURINE; 2 PHENYLAMINO 9 (4 HYDROXYBUTYL) 6 OXOPURINE; 2 PHENYLAMINO 9 (N,N DIMETHYLAMINOBUTYL) 6 OXOPURINE; 5 (BROMOVINYL)DEOXYURIDINE; 5 BROMOVINYLDEOXYURIDINE; 5 PROPYLDEOXYURIDINE; ACICLOVIR; ACYCLIC NUCLEOSIDE; ANTIVIRUS AGENT; CIDOFOVIR; EDOXUDINE; GANCICLOVIR; IDOXURIDINE; N 2 (3 TRIFLUOROMETHYLPHENYL)GUANINE; PENCICLOVIR; THYMIDINE KINASE; THYMIDINE KINASE INHIBITOR; TRIFLURIDINE; UNCLASSIFIED DRUG; URIDINE;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CERCOPHITECINE HERPESVIRUS 1; CONTROLLED STUDY; CYTOTOXICITY; DNA SEQUENCE; DRUG EFFECT; DRUG STRUCTURE; ENANTIOMER; ENANTIOSELECTIVITY; ENZYME PHOSPHORYLATION; HERPES SIMPLEX VIRUS; HERPES VIRUS; IC 50; MONKEY B VIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; VERO CELL; VIRUS REPLICATION;

ACYCLOVIR; AMINO ACID SEQUENCE; ANIMALS; ANTIVIRAL AGENTS; CERCOPITHECUS AETHIOPS; DEOXYURIDINE; ENZYME INHIBITORS; HERPESVIRUS 1, CERCOPITHECINE; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; NUCLEOSIDES; PHOSPHORYLATION; SUBSTRATE SPECIFICITY; THYMIDINE; THYMIDINE KINASE; VERO CELLS;

EID: 34250213252     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.01284-06     Document Type: Article

References (22)

1. Boulter, E. A., B. Thornton, F. J. Bauer, and A. Bye. 1980. Successful treatment of experimental B virus (Herpesvirus simiae) infection with acyclovir. Br. Med. J. 280:681-682.
2. Cheng, Y.-C., G. Dutschman, E. DeClercq, E. A. Jones, S. G. Rahim, G. Verhelst, and R. T. Walker. 1981. Differential affinities of 5-(2-halogenovinyl)-2′-deoxyuridines for deoxythymidine kinases of various origins. Mol. Pharmacol. 20:230-233.
3. Cohen, J. I., J. S. Davenport, J. A. Stewart, S. Deitchmann, J. K. Hilliard, L. E. Chapman, and the B Virus Working Group. 2002. Recommendations for prevention of and therapy for exposure to B virus (Cercopithecine Herpesvirus 1). Clin. Infect. Dis. 35:1191-1203.
4. Davis, W. B., J. E. Oakes, J. P. Vacik, R. R. Rebert, and J. A. Taylor. 1979. 5-Ethyl-2′-deoxyuridine as a systemic agent for treatment of herpes simplex virus encephalitis. Comparison of effects in a normal and immunosuppressed murine model, p. 140-150. In K. K. Gauri (ed.), Anti-herpesvirus chemotherapy: experimental and clinical aspects. Karger, Basel, Switzerland.
5. De Clercq, E., J. Descamps, and D. Shugar. 1978. 5-Propyl-2′-deoxyuridine: a specific anti-herpes agent. Antimicrob. Agents Chemother. 13:545-547.
6. DeClercq, E. 1984. Biochemical aspects of the selective antiherpes activity of nucleoside analogues. Biochem. Pharmacol. 33:2159-2169.
7. Elze, K.-L. 1979. Ten years of clinical experiences with ethyldeoxyuridine, p. 134-139. In K. K. Gauri (ed.), Anti-herpesvirus chemotherapy: experimental and clinical aspects. Karger, Basel, Switzerland.
8. Focher, F., S. Spadari, and G. Maga. 2003. Antivirals at the mirror: the lack of stereospecificity of some viral and human enzymes offers novel opportunities in antiviral drug development. Curr. Drug Targets Infect. Disord. 3:41-53.
9. Keller, P. M., J. A. Fyfe, L. Beauchamp, C. M. Lubbers, P. A. Furman, H. J. Schaeffer, and G. B. Elion. 1981. Enzymatic phosphorylation of acyclic nucleoside analogs and correlations with antiherpetic activities. Biochem. Pharmacol. 30:3071-3076.
10. Larsson, A., S. Alenius, N. G. Johansson, and B. Öberg. 1983. Antiherpetic activity and mechanism of action of 9-(4-hydroxybutyI)guanine. Antivir. Res. 3:77-86.
11. Larsson, A., K. Stenberg, A.-C. Ericson, U. Hagland, W.-A. Yisak, N. G. Johansson, B. Öberg, and R. Datema. 1986. Mode of action, toxicity, pharmacokinetics, and efficacy of some new antiherpesvirus guanosine analogs related to buciclovir. Antimicrob. Agents Chemother. 30:598-605.
12. Maga, G., A. Verri, W. Ponti, L. Bonizzi, G. Poli, A. Garbesi, D. Niccolai, S. Spadari, and F. Focher. 1993. Lack of stereospecificity of suid pseudorabies virus (PRV) thymidine kinase. Biochem. J. 294:381-385.
13. Manikowski, A., A. Verri, A. Lossani, B. M. Gebhardt, J. Gambino, F. Focher, S. Spadari, and G. E. Wright. 2005. Inhibition of herpes simplex virus thymidine kinases by 2-phenylamino-6-oxopurines and related compounds: structure-activity relationships and antiherpetic activity in vivo. J. Med. Chem. 48:3919-3929.
14. L region of other primate herpesviruses. Arch. Virol. 148:989-997.
15. Ritchey, J. W., M. E. Payton, and R. Eberle. 2005. Clinicopathological characterization of monkey B virus (Cercopithecine herpesvirus 1) infection in mice. Comp. Med. 55:246-250.
16. Spadari, S., G. Maga, F. Focher, G. Ciarrocchi, R. Manservigi, F. Arcamone, M. Capobianco, A. Carcuro, F. Colonna, S. Iotti, and A. Garbesi. 1992. L-Thymidine is phosphorylated by herpes simplex virus type 1 thymidine kinase and inhibits viral growth. J. Med. Chem. 35:4214-4220.
17. Spadari, S., G. Ciarrocchi, F. Focher, A. Verri, G. Maga, F. Arcamone, E. Iafrate, S. Manzini, A. Garbesi, and L. Tondelli. 1995. 5-Iodo-2′-deoxy-L-uridine (L-IdU) and (E)-5-(2-bromovinyl)-2′-deoxy- L-uridine (L-BVdU): selective phosphorylation by herpes simplex virus type 1 thymidine kinase, antiherpetic activity and cytotoxicity studies. Mol. Pharmacol. 47:1231-1238.
18. Swierkowski, M., and D. Shugar. 1969. A nonmutagenic thymidine analog with antiviral activity: 5-ethyldeoxyuridine. J. Med. Chem. 12:533-534.
19. Whitley, R. J. 1996. Cercopithecine herpes virus 1 (B virus), p. 2623-2635. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fields virology, 3rd ed. Lippincott Raven, Philadelphia, PA.
20. Wright, G. E., and N. C. Brown. 1990. Deoxyribonucleotide analogs as inhibitors and substrates of DNA polymerases. Pharm. Ther. 47:447-497.
21. Wright, G. E., J. J. Gambino, H. Sun, and B. M. Gebhardt. 1999. Status of inhibitors of herpes simplex thymidine kinase. Curr. Opin. Anti-infect. Drugs 1:541-546.
22. 2-phenylguanine derivatives as inhibitors of herpes simplex virus thymidine kinases. J. Med. Chem. 38:87-94.